RecruitingNot ApplicableNCT05553899
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours
Utility of PET-MRI in Post-treatment Surveillance of Paediatric Brain Tumours: a Pilot Study
Sponsor
Sheffield Children's NHS Foundation Trust
Enrollment
5 participants
Start Date
Feb 28, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This is a pilot project to explore the utility of PET-MRI in the post-treatment surveillance of high-grade gliomas or medulloblastomas in children in our institution.
Eligibility
Min Age: 8 YearsMax Age: 18 Years
Inclusion Criteria4
- Have a presumptive or histologically confirmed diagnosis of a malignant brain tumour requiring treatment
- Diagnostic uncertainty about tumour recurrence post-treatment based on conventional MR imaging in the opinion of the MDT
- Have a life expectancy of at least three months
- Able to comply with an MRI scan without a general anaesthetic
Exclusion Criteria5
- Unable to comply with an MRI scan without a general anaesthetic
- Diabetes or other causes of hyperglycaemia
- Pregnancy
- Patient body habitus above scanner dimensions
- Standard contra-indication to MRI (eg. pacemaker, non-compatible metallic implants, altered renal function)
Interventions
RADIATIONPET-MRI
magnetic resonance imaging with positron emission tomography scanning using the tracer 18F-FDG
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05553899
Related Trials
Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
NCT0659987915 locations
Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)
NCT073385261 location
Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
NCT069055874 locations
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
NCT063092513 locations
GD2-CAR T Cells for Pediatric Brain Tumours
NCT052989951 location